Here, it has been demonstrated for the first time that SEMA, a GLP-1RA with known pharmacological effects on metabolic syndrome [43, 44], is able to reshape PDAC stroma preventing T lymphocyte exclusion by P4HA1-collagen-pCAF axis (Fig. 3 and Fig. 4). This evidence concerns the gene P4HA1 and metabolic syndrome.